Compound 24
Compound 24 has been studied in 1 paper since 2023: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Jul 20, 2026: “Uncertainty-Aware Ranking of Geroprotective Interventions from Public Lifespan Data: A Sentinel Cross-Species Benchmark”.
- 1 lab in 1 country
- Funders: National Institute on Aging and 1 more
- Cells1
What did studies of Compound 24 find?
1Studies of Compound 24 measured 1 outcome; the most studied are cellular senescence (1 study).
Cellular senescence
downin human cells1
1 study
Cellular senescence
downin human cells1
Compound 24 inhibits cellular senescence in human cells (50-fold enhancement compared to PL).
“compound 24, which exhibited an impressive 50-fold enhancement in senolytic activity against senescent WI-38 fibroblasts compared to PL”
Cellsin senescent WI-38 fibroblasts
Design and optimization of piperlongumine analogs as potent senolytics
Bioorganic & medicinal chemistry letters
Latest
1 paper in 12 monthsZenodo
Uncertainty-Aware Ranking of Geroprotective Interventions from Public Lifespan Data: A Sentinel Cross-Species Benchmark
Preprint: computational studyAI & data
Bioorganic & Medicinal Chemistry Letters
Design and optimization of piperlongumine analogs as potent senolytics
Experiments in human cellsSenolytics